A phase 2 randomized study of modakafusp alfa as a single agent for patients with relapsed/refractory multiple myeloma
一项针对复发/难治性多发性骨髓瘤患者的莫达卡福斯普α单药治疗的II期随机研究
期刊:Blood
影响因子:23.1
doi:10.1182/blood.2024027873
Holstein, Sarah A; Atrash, Shebli; Mian, Hira; Dimopoulos, Meletios A; Schjesvold, Fredrik; Popat, Rakesh; Shah, Nishi; Gatt, Moshe E; Gocke, Christian B; Frenzel, Laurent; Touzeau, Cyrille; Beksac, Meral; Manier, Salomon; Magen, Hila; Travis, Patrick; Nadeem, Omar; Suryanarayan, Kaveri; Li, Cheryl; Li, Shuli; Nelson, Allison; Cherepanov, Dasha; Parot, Xavier; Vogl, Dan T